These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 21075901)

  • 21. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
    Gupta N; Kumar R; Agrawal B
    Front Immunol; 2018; 9():709. PubMed ID: 29692778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenesis of post-primary tuberculosis. A game changer for vaccine development.
    Hunter R; Actor J
    Tuberculosis (Edinb); 2019 May; 116S():S114-S117. PubMed ID: 31076321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis.
    Etna MP; Giacomini E; Severa M; Coccia EM
    Semin Immunol; 2014 Dec; 26(6):543-51. PubMed ID: 25453229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection.
    Arcos J; Sasindran SJ; Fujiwara N; Turner J; Schlesinger LS; Torrelles JB
    J Immunol; 2011 Jul; 187(1):372-81. PubMed ID: 21602490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.
    Troy A; Esparza-Gonzalez SC; Bartek A; Creissen E; Izzo L; Izzo AA
    Tuberculosis (Edinb); 2020 Jul; 123():101949. PubMed ID: 32741537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis.
    Semple PL; Binder AB; Davids M; Maredza A; van Zyl-Smit RN; Dheda K
    Am J Respir Crit Care Med; 2013 Jun; 187(11):1249-58. PubMed ID: 23590266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary responses to pathogen-specific antigens in latent Mycobacterium tuberculosis infection.
    Jarvela JR; Tuscano L; Lee H; Silver RF
    Tuberculosis (Edinb); 2016 Jan; 96():158-64. PubMed ID: 26732045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of innate cytokines in mycobacterial infection.
    Cooper AM; Mayer-Barber KD; Sher A
    Mucosal Immunol; 2011 May; 4(3):252-60. PubMed ID: 21430655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.
    Kondratieva TK; Kapina MA; Rubakova EI; Kondratieva EV; Nikonenko BV; Majorov KB; Dyatlov AV; Linge IA; Apt AS
    Tuberculosis (Edinb); 2018 Dec; 113():130-138. PubMed ID: 30514495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The α4β1 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung.
    Walrath JR; Silver RF
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):24-30. PubMed ID: 20724551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alveolar Epithelial Cells in Mycobacterium tuberculosis Infection: Active Players or Innocent Bystanders?
    Scordo JM; Knoell DL; Torrelles JB
    J Innate Immun; 2016; 8(1):3-14. PubMed ID: 26384325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokines in tuberculosis: the good, the bad and the ugly.
    Monin L; Khader SA
    Semin Immunol; 2014 Dec; 26(6):552-8. PubMed ID: 25444549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
    Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
    J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Gupta A; Saqib M; Singh B; Pal L; Nishikanta A; Bhaskar S
    Front Immunol; 2019; 10():2359. PubMed ID: 31681272
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Ryndak MB; Laal S
    Front Cell Infect Microbiol; 2019; 9():299. PubMed ID: 31497538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
    Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
    Front Immunol; 2020; 11():575504. PubMed ID: 33117374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection.
    Silver RF; Myers AJ; Jarvela J; Flynn J; Rutledge T; Bonfield T; Lin PL
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):899-908. PubMed ID: 27509488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
    Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
    Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?
    Ronacher K; Sinha R; Cestari M
    Front Immunol; 2018; 9():2209. PubMed ID: 30319650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.